.png?width=1900&height=550&name=310W25-HERO-EMAIL-FINAL%20(1).png)
8:00 AM
Networking
Registration and Networking Breakfast
8:45 AM
Opening
Opening Remarks
9:00 AM
Keynote
From Clinical Milestones to Commercial Momentum: Building a Seamless Path to Launch
- Translating pivotal trial strategy into a differentiated launch narrative that resonates with regulators, payers, HCPs, and patients
- Identifying critical inflection points during Phase II/III where commercial, medical, and access teams must engage early
- Designing cross-functional governance models that prevent “handoff gaps” between clinical and commercial
- Aligning endpoints, HEOR strategy, and real-world evidence plans to support pricing, reimbursement, and field readiness
- Building internal launch readiness dashboards that integrate clinical progress with operational and commercial KPIs
- Avoiding common pitfalls: late market shaping, misaligned messaging, and siloed decision-making
9:45 AM
Session
Inside the Launch Decision Room: An Interview on the Choices That Make or Break a Product Launch
Go Behind the Scenes of Real Executive Decision-Making During the Critical 12–24 Months Leading Up to Launch
- Explore how leaders prioritize investments, manage risk, and balance speed vs. certainty across Medical, Commercial, and Market Access
- Learn how leadership teams align the entire organization around launch milestones, KPIs, and accountability
- Hear real examples of KOL/HCP impact as well as successful partnerships with disease state associations
- Understand how cross-functional collaboration can break down silos to accelerate readiness
Safia Rizvi
CEO · Cila Therapeutics
10:45 AM
Break
Networking Break
11:15 AM
Panel
From Strategy to Uptake: Building a Commercial Launch Engine That Drives Awareness, Adoption, and Growth
- Translate brand strategy into a launch-ready commercial plan that aligns marketing, sales, market access, and analytics
- Build a scalable pre-launch awareness strategy through segmentation, targeting, and omnichannel engagement
- Design the field readiness model—training, messaging, tools, and KPIs—for confident execution from day one
- Leverage data, AI, and predictive analytics to identify priority audiences and optimize launch performance
- Align commercial messaging with Medical Affairs and Market Access for consistent, differentiated value communication
Frank Nazzario
VP, Commercial · Larimar Therapeutics
Archana Sondhi
VP Marketing & Commercial Strategy · IDEAYA Biosciences
Keith White
VP, Commercial · Disc Medicine
Marina Orlova
Executive Director, Commercial Strategy · Merck
12:30 PM
Break
Networking Lunch
1:30 PM
Session
From Gap to Growth: Building Market Readiness Before Launch Through Disease Awareness, Partnerships, and Real-World Insight
- Identifying healthcare system gaps, unmet needs, and disease recognition opportunities to shape the environment before launch
- Building early disease-state awareness campaigns through education, messaging, and competitive landscape analysis
- Partnering with professional societies, HCP congresses, advisory boards, and strategic collaborators early
- Using market research, patient advisory boards, and RWE to refine messaging and demonstrate impact
2:15 PM
Session
Building the AI-Enabled Launch Engine: Embedding Intelligent Workflows Across Marketing, Sales, and Commercial Operations
- Design scalable marketing and commercial systems for multiple launches, new indications, and reformulations
- Embed AI into core workflows across promotional review, content lifecycle, speaker programs, and campaign execution
- Connect marketing technologies, fulfillment systems, and CRM platforms for a unified launch ecosystem
- Practical strategies for making AI a core operating model to drive measurable commercial launch impact
Mark Burns
Director, Marketing Operations · Avidity Biosciences
2:45 PM
Break
Networking Break
3:15 PM
Session
From Data to Narrative: Communicating Scientific Value to All Stakeholders Before and Beyond Launch
- Transforming clinical data into compelling, compliant narratives that communicate scientific value and differentiation
- Aligning corporate, medical, and commercial messaging across publications, media, investor updates, and launch materials
- Preparing for high-visibility milestones including pivotal data readouts, regulatory decisions, and approval announcements
- Building cross-functional collaboration between Medical Affairs, Corporate Communications, and Commercial teams
Sarah Strattman
Global Communications Lead · Vertex Pharmaceuticals
4:00 PM
Panel
Medical Affairs as the Strategic Launch Engine: Building the Team, Evidence, and Engagement Model for Launch Success
- Define how Medical Affairs leaders can shape launch strategy early by aligning evidence generation and cross-functional decision making
- Build and scale a high-impact Medical Affairs launch team—roles, capabilities, resourcing, and training
- Develop a modern KOL engagement strategy blending traditional thought leaders, rising experts, and digital opinion leaders
- Create a compliant, scalable scientific engagement model that strengthens HCP relationships before, during, and after launch
- Measure Medical Affairs launch impact using clear metrics and dashboards that demonstrate value to leadership
Daniela van Eickels, MD, PhD, MPH
SVP, CMO Head of Medical Affairs · Kyowa Kirin
Taylor Salinardi, PhD
VP, Global Head Medical Ops & Excellence · Azurity Pharmaceuticals
Carolyn Reever, PhD
Global Head, Neuropsychiatry & Epilepsy Medical Affairs · Biogen
Caroline Ojaimi
Executive Director, Medical Affairs Operations · BioNTech
Anna Murzhenko, PharmD
Medical Affairs Leader
Noelle Griffin
Global Head Nephrology & Transplant Medical Affairs · Biogen
5:30 PM
Closing
End of Day One
8:00 AM
Networking
Networking Breakfast
8:45 AM
Opening
Opening Remarks
9:00 AM
Keynote
Commercial Launch Readiness: Aligning Sales, Marketing, Access & Operations for Customer Engagement
- From Insight to Execution: How customer insights shape commercial strategy and influence launch readiness
- Designing the Sales Organization for Launch: Building the right field structure and sales force effectiveness model
- Startup vs. Established Company Launch Models: Table stakes for building commercial infrastructure in emerging biotech
- Market Access Integration: Incorporating payer and provider perspectives early, including HEOR strategy and value evidence
- Driving Customer Engagement at Launch: Aligning commercial teams for meaningful engagement with providers and stakeholders
10:00 AM
Session
Channel Strategy and Trade Readiness: Aligning Market Access, Distribution, and Commercial Execution for Launch
- Designing the right channel model based on product characteristics, patient population, and market access strategy
- Leveraging pre-approval information exchange (PIE) to engage payers early
- Preparing trade and distribution operations including specialty distributor contracts and inventory planning
- Why trade strategy is often the “forgotten child” of launch planning and how to elevate its importance
10:45 AM
Break
Networking Break
11:15 AM
Session
Build Patient-Powered Launches: Strategic Partnerships with Advocacy Groups, Nonprofits & Disease Communities
- Build relationships with patient communities and advocacy organizations 12–24 months pre-launch
- Partner with advocacy groups to co-create education, support programs, and disease awareness initiatives
- Navigate compliance and regulatory considerations while maintaining authentic patient engagement
- Define and track meaningful KPIs to measure patient engagement impact on access, adoption, and outcomes
Tina Rezakhani, PharmD, MBA
US Medical Affairs – Rare Disease | Board Member · Sanofi | Amedea Pharma
12:00 PM
Networking
Networking Lunch
1:00 PM
Panel
From Insight to Impact: Building a Data-Driven Field Engagement Strategy that Drives Launch Success
- Translate field insights from MSLs, KAMs, and field teams into actionable strategy
- Identify and prioritize the right stakeholders including KOLs, community experts, and digital opinion leaders
- Leverage engagement platforms, CRM systems, and insight management tools to capture field intelligence
- Connect field insights back to Medical, Commercial, Market Access, and Evidence Generation teams
Lynn Bass, PharmD
Medical Affairs Lead, Rare Disease Hematology · Mesoblast
Ana Bozas, PhD, CMPP
Medical Affairs & Medical Communications Leader
Sanaz Cardoza
Medical Affairs Strategy Leader
Michael Liberman
Senior Medical Director – Pipeline · Exelixis
2:00 PM
Session
Building Launch Alignment: How Medical Insights Shape Commercial Strategy, Messaging, and Execution
- Early Medical Affairs engagement during Phase III to ensure clinical insights inform commercial launch strategy
- Aligning Medical and Commercial teams around shared disease state education and key data messaging
- Developing speaker bureau and peer-to-peer programs that translate unmet needs into credible HCP education
- Creating a culture that supports cross-functional collaboration through empowerment and recognition
Amy Everitt, PharmD, MS
Sr. Director, Medical Promotional Review & Field Scientific Excellence · Alkermes
2:45 PM
Session
Exchange to Market Momentum: Designing HCP Engagement That Drives Launch Impact
- Translating early Phase III scientific insights into messaging that resonates with HCPs at launch
- Navigating the medical-to-commercial transition while maintaining credibility and scientific integrity
- Engaging KOLs early to shape educational content, disease awareness, and clinical narratives
- Developing scalable speaker bureau programs and field education initiatives that activate quickly at launch
Bree Kuntz
Senior Product Manager, HCP Marketing · Verona Pharmaceuticals
3:30 PM
Closing
Conference Ends
